Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating bordetella bronchiseptica-reactive antibody responses in seropositive dogs

Journal of the American Veterinary Medical Association

Volumn 220, Issue 1, 2002, Pages 43-48

  Ellis, John A ^a   Krakowka, G Steven ^b   Dayton, Arthur D ^c   Konoby, Carrie ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b OHIO STATE UNIVERSITY   (United States)

^c ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BORDETELLA BRONCHISEPTICA VACCINE; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; SECRETORY IMMUNOGLOBULIN;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; BORDETELLA BRONCHISEPTICA; CONTROLLED STUDY; DOG; DRUG EFFICACY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; NONHUMAN; RESPIRATORY TRACT DISEASE; ANIMAL; BACTERIAL INFECTION; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; DOG DISEASE; FEMALE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MUCOSAL IMMUNITY; PHARYNX; RANDOMIZATION; SALIVA; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; CANIS FAMILIARIS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; DOG DISEASES; DOGS; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; PHARYNX; RANDOM ALLOCATION; SALIVA; TREATMENT OUTCOME; VACCINATION;

EID: 0036139703     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.220.43     Document Type: Article

References (29)

1. Keil DJ, Fenwick B. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs. J Am Vet Med Assoc 1998;212: 200-207.
2. Ford RB, Vaden SL. Canine infectious tracheobronchitis. In: Greene CE, ed. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;35-38.
3. Nelson RW, Cuoto CG. Disorders of the trachea and bronchi. In: Small animal internal medicine. St Louis: CV Mosby Co, 1998;285-287.
4. McCandlish IAP, Thompson H, Wright NG. Vaccination against canine bordetellosis using an aluminum hydroxide adjuvant vaccine. Res Vet Sci 1978;25:51-57.
5. Bey RF, Shade FJ, Goodnow RA, et al. Intranasal vaccination of dogs with live avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis. Am J Vet Res 1981;42:1130-1132.
6. Glickman LT, Appel MJ. Intranasal vaccine trial for canine infectious tracheobronchitis (kennel cough). Lab Anim Sci 1981;31: 397-399.
7. Kontor EJ, Wegrzyn RJ, Goodnow RA. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough). Am J Vet Res 1981;42:1694-1698.
8. Shade FJ, Rapp VJ. Studies of a bacterin incorporating an extracted Bordetella bronchiseptica antigen for controlling canine bordetellosis. Vet Med Small Anim Clin 1982;77:1635-1639.
9. Ellis JA, Haines DM, West KH, et al. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. J Am Vet Med Assoc 2001;218:367-375.
10. Keitel WA, Cate TR, Nino D, et al. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. J Infect Dis 2001;183:329-332.
11. Ford RB, Schultz RD. Vaccines and vaccinations: issues in the 21st century. In: Bonagura JD, ed. Kirk's current veterinary therapy XIII. Philadelphia: WB Saunders Co, 2000;250-253.
12. Ford RB. Infectious tracheobronchitis. In: Bonagura JD, ed. Kirk's current veterinary therapy XII. Philadelphia: WB Saunders Co, 1995;905-908.
13. Gerber, JD, Ingersoll JD, Gast AM, et al. Protection against feline infectious peritonitis by intranasal inoculation of a temperature sensitive vaccine. Vaccine 1990;8:536-542.
14. Boot R, Bakker RHG, Thuis H, et al. An enzyme-linked immunosorbent assay (ELISA) for monitoring guinea pigs and rabbits for Bordetella bronchiseptica. Lab Animals 1993;27:350-357.
15. Malvano R, Boniolo A, Dovis M, et al. ELISA for antibody measurement: aspects related to data expression J Immunol Methods 1982;48:51-60.
16. Harris DL, Switzer WP. Immunization of pigs against B bronchiseptica infection by parenteral immunization. Am J Vet Res 1972;33:1975-1984.
17. Barry AL. Clinical specimens for microbiological examination. In: Haeprich PD, ed. Infectious diseases: a guide to the understanding and management of the infectious process. New York: Harper & Row, 1972;103-107.
18. SAS system for mixed models. Cary, NC: SAS Institute Inc. 1990;632.
19. Cherry JD. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials. Pediatr Infect Dis J 1997;16: S90-S96.
20. Tizard IR. Immunity in the fetus and newborn. In: Veterinary immunology: an introduction. 6th ed. Philadelphia: WB Saunders Co, 2000;210-221.
21. Tizard IR. Immunity at body surfaces. In: Veterinary immunology: an introduction. 6th ed. Philadelphia: WB Saunders Co, 2000;222-234.
22. Hathaway LJ, Kraehenbuhl JP. The role of M cells in mucosal immunity. Cell Mol Life Sci 2000;57:323-332.
23. Vaerman JP, Heremans JF. Origin and molecular size of immunoglobulin-A in the mesenteric lymph of the dog. Immunology 1970;18:27-38.
24. Felsburg PJ. Immunology of the dog. In: Pastoret PP, Griebel P, Bazin H, et al. eds. Handbook of vertebrate immunology. San Diego: Academic Press, 1998;261-288.
25. Goodnow RA, Shade FJ, Switzer WP. Efficacy of Bordetella bronchiseptica bacterin in controlling enzootic atrophic rhinitis in swine. Am J Vet Res 1979;40:58-60.
26. Smith IM, Giles CJ, Baskerville AJ. Immunisation of pigs against experimental infection with Bordetella bronchiseptica. Vet Res 1982;110:488-494.
27. Giuliano M, Mastrantonio P, Giammanco A, et al. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 1998;132:983-988.
28. Ausiello CM, Lande R, Urbani F, et al. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J Infect Dis 2000;181:1989-1995.
29. Ausiello CM, Lande R, Urbani F, et al. Cell-mediated immune responses in four-year old children after primary immunization with acellular pertussis vaccines. Infect Immun 1999;67: 4064-4071.